Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03875534 · ClinicalTrials.gov registry record
A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia
A clinical trial, sponsored by Ascendis Pharma A/S.
- Completed
- Registry status
- 260
- Enrollment target
NCT03875534 is a clinical trial that has completed, run by Ascendis Pharma A/S. The registered enrollment target is 260 participants.
The verdict
NCT03875534 has completed, sponsored by Ascendis Pharma A/S.
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
This is a long-term, multi-center, longitudinal, observational study in children with achondroplasia (ACH). The aim is to study height velocity and comorbidities in children with ACH. This is a natural history study and no study medication will be administered.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2019-06-19 |
| Est. Completion | 2024-01-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03875534
The ClinicalTrials.gov registry entry for NCT03875534 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascendis Pharma A/S, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03875534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03875534 about?
NCT03875534 is a clinical study titled "A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia". This is a long-term, multi-center, longitudinal, observational study in children with achondroplasia (ACH). The aim is to study height velocity and comorbidities in children with ACH. This is a natural history study and no study medication will be administered.
What is the current status of trial NCT03875534?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2019-06-19. Estimated completion is 2024-01-12.
Who is sponsoring clinical trial NCT03875534?
This trial is sponsored by Ascendis Pharma A/S, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.